Product Recalls in District of Columbia

Product recalls affecting District of Columbia — including food, drugs, consumer products, medical devices, and vehicles distributed to District of Columbia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,448 recalls have been distributed to District of Columbia in the last 12 months.

47,654 total recalls
2,448 in last 12 months

Showing 2910129120 of 47,654 recalls

Medical DeviceApril 20, 2017· Biomerieux Inc

Recalled Item: VITEK¿ 2 Gram Negative Susceptibility card (AST-XN05) Recalled by Biomerieux...

The Issue: The integrity of the product container may be compromised thereby exposing...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 20, 2017· Biomerieux Inc

Recalled Item: VITEK¿ 2 Gram Negative Susceptibility card (AST-GN87) Recalled by Biomerieux...

The Issue: The integrity of the product container may be compromised thereby exposing...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 20, 2017· Biomerieux Inc

Recalled Item: VITEK¿ 2 Gram Positive Susceptibility card (AST-P633) Recalled by Biomerieux...

The Issue: The integrity of the product container may be compromised thereby exposing...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 20, 2017· Biomerieux Inc

Recalled Item: VITEK¿ 2 Gram Negative Susceptibility card (AST-N231) Recalled by Biomerieux...

The Issue: The integrity of the product container may be compromised thereby exposing...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceApril 20, 2017· Biomerieux Inc

Recalled Item: VITEK¿ 2 Gram Negative Susceptibility card (AST-N355) Recalled by Biomerieux...

The Issue: The integrity of the product container may be compromised thereby exposing...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugApril 20, 2017· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection Recalled by Akorn, Inc. Due to...

The Issue: Product is being recalled due to low pH value.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Amitriptyline HCL Tablets Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Labeling: Labeled...

The Issue: Labeling: Labeled Error on Declared Strength; report of a 1000 ct bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 10 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 12.5 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 20 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 6 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 15 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 25 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 18 mg pellet Recalled by Qualgen Due to CGMP deviations- Lack of...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 22 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund